These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 9164971

  • 21. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
    Zeller GC, Hirahashi J, Schwarting A, Sharpe AH, Kelley VR.
    J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836
    [Abstract] [Full Text] [Related]

  • 22. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 23. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3572-82. PubMed ID: 16207826
    [Abstract] [Full Text] [Related]

  • 24. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 01; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 25. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice.
    Kökény G, Godó M, Nagy E, Kardos M, Kotsch K, Casalis P, Bodor C, Rosivall L, Volk HD, Zenclussen AC, Hamar P.
    Lupus; 2007 May 01; 16(7):465-77. PubMed ID: 17670844
    [Abstract] [Full Text] [Related]

  • 26. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE, Wofsy D, Greenspan JS, Ledbetter JA.
    J Immunol; 1983 Apr 01; 130(4):1713-8. PubMed ID: 6187819
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH.
    Arthritis Rheum; 2004 Jun 01; 50(6):1884-96. PubMed ID: 15188365
    [Abstract] [Full Text] [Related]

  • 30. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
    Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED.
    J Immunol; 1984 Jul 01; 133(1):227-33. PubMed ID: 6609979
    [Abstract] [Full Text] [Related]

  • 31. Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses.
    Allam R, Pawar RD, Kulkarni OP, Hornung V, Hartmann G, Segerer S, Akira S, Endres S, Anders HJ.
    Eur J Immunol; 2008 Dec 01; 38(12):3487-98. PubMed ID: 19009528
    [Abstract] [Full Text] [Related]

  • 32. G-rich DNA suppresses systemic lupus.
    Patole PS, Zecher D, Pawar RD, Gröne HJ, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 Nov 01; 16(11):3273-80. PubMed ID: 16176997
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 01; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L, Santiago ML, Takahashi S, Fossati L, Izui S.
    Ann Med Interne (Paris); 1996 Sep 01; 147(7):467-71. PubMed ID: 9092356
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The cellular basis for immune interferon production in autoimmune MRL-Ipr/Ipr mice.
    Santoro TJ, Benjamin WR, Oppenheim JJ, Steinberg AD.
    J Immunol; 1983 Jul 01; 131(1):265-8. PubMed ID: 6408174
    [Abstract] [Full Text] [Related]

  • 39. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.
    Arthritis Rheum; 2002 Nov 01; 46(11):3083-95. PubMed ID: 12428253
    [Abstract] [Full Text] [Related]

  • 40. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX, Xiao BG, Bai XF, van der Meide PH, Orn A, Link H.
    J Immunol; 1999 Apr 01; 162(7):3775-81. PubMed ID: 10201893
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.